Structures by: Bag P. P.
Total: 40
C75H45Fe11O57,5.23(O)
C75H45Fe11O57,5.23(O)
Inorganica Chimica Acta (2015) 425, 61-66
a=14.600(3)Å b=14.602(3)Å c=23.236(4)Å
α=99.165(5)° β=99.281(5)° γ=94.805(5)°
C8H2Br4O4,C5H4BrN
C8H2Br4O4,C5H4BrN
CrystEngComm (2020)
a=8.8412(19)Å b=9.012(2)Å c=12.227(3)Å
α=70.384(3)° β=71.053(3)° γ=77.807(4)°
C8H2Br4O4,C8Br4O4,2(C5H7N2),2(H2O)
C8H2Br4O4,C8Br4O4,2(C5H7N2),2(H2O)
CrystEngComm (2020)
a=8.914(2)Å b=10.446(3)Å c=10.466(3)Å
α=65.089(7)° β=86.050(8)° γ=75.658(8)°
C8H2Br4O4,C8Br4O4,2(C6H7N2O),2(H2O)
C8H2Br4O4,C8Br4O4,2(C6H7N2O),2(H2O)
CrystEngComm (2020)
a=9.0292(10)Å b=9.4163(11)Å c=12.2764(14)Å
α=108.671(2)° β=108.502(2)° γ=93.051(2)°
4(C8HBr4O4),4(C5H7N2),5(H2O)
4(C8HBr4O4),4(C5H7N2),5(H2O)
CrystEngComm (2020)
a=9.4075(4)Å b=18.8184(5)Å c=21.0347(9)Å
α=90° β=90° γ=90°
C168H118N10O31Zn8
C168H118N10O31Zn8
Chemical communications (Cambridge, England) (2016) 52, 18 3669-3672
a=15.4739(2)Å b=57.1814(6)Å c=24.7469(3)Å
α=90.00° β=94.6020(10)° γ=90.00°
C17H23N3O2
C17H23N3O2
Physical chemistry chemical physics : PCCP (2015) 17, 32 20515-20521
a=6.8038(3)Å b=17.3110(6)Å c=13.4729(5)Å
α=90.00° β=99.2990(10)° γ=90.00°
C16H20N2O3
C16H20N2O3
Physical chemistry chemical physics : PCCP (2015) 17, 32 20515-20521
a=7.1834(5)Å b=12.7135(8)Å c=16.5140(11)Å
α=90.00° β=97.201(2)° γ=90.00°
C17H23N3O2
C17H23N3O2
Physical chemistry chemical physics : PCCP (2015) 17, 32 20515-20521
a=10.896(6)Å b=7.886(5)Å c=19.222(9)Å
α=90.00° β=94.135(12)° γ=90.00°
C16H20N2O3
C16H20N2O3
Physical chemistry chemical physics : PCCP (2015) 17, 32 20515-20521
a=13.818(6)Å b=7.428(3)Å c=15.482(7)Å
α=90.00° β=93.055(9)° γ=90.00°
Ciprofloxacin diflunisal salt
C30H26F3N3O6
CrystEngComm (2014) 16, 32 7393
a=7.116(2)Å b=9.994(4)Å c=19.147(7)Å
α=81.470(9)° β=82.505(8)° γ=87.191(8)°
Ciprofloxacin indoprofen hydrate salt
C34H35FN4O7
CrystEngComm (2014) 16, 32 7393
a=10.325(4)Å b=12.615(5)Å c=12.916(5)Å
α=71.510(7)° β=74.334(7)° γ=70.672(7)°
Ciprofloxacin diflunisal salt
C30H26F3N3O6
CrystEngComm (2014) 16, 32 7393
a=7.116(2)Å b=9.994(4)Å c=19.147(7)Å
α=81.470(9)° β=82.505(8)° γ=87.191(8)°
Ciprofloxacin indoprofen hydrate salt
C34H35FN4O7
CrystEngComm (2014) 16, 32 7393
a=10.325(4)Å b=12.615(5)Å c=12.916(5)Å
α=71.510(7)° β=74.334(7)° γ=70.672(7)°
Succinylsulfathiazole plymorph I
C13H13N3O5S2
CrystEngComm (2014) 16, 22 4706
a=8.8478(4)Å b=13.3523(6)Å c=14.1584(6)Å
α=67.9870(10)° β=77.1140(10)° γ=74.6120(10)°
Succinylsulfathiazole plymorph II
C13H13N3O5S2
CrystEngComm (2014) 16, 22 4706
a=11.351(3)Å b=8.577(2)Å c=16.684(3)Å
α=90.00° β=107.483(5)° γ=90.00°
Succinylsulfathiazole mono hydrate
C13H15N3O6S2
CrystEngComm (2014) 16, 22 4706
a=16.190(6)Å b=5.1460(14)Å c=19.449(7)Å
α=90.00° β=94.028(17)° γ=90.00°
Succinylsulfathiazole acetone solvate
C29H32N6O11S4
CrystEngComm (2014) 16, 22 4706
a=8.5229(4)Å b=14.5887(7)Å c=15.2327(7)Å
α=64.7770(10)° β=78.1610(10)° γ=82.0860(10)°
Succinylsulfathiazole tetrahydrofuran solvate
C30H34N6O11S4
CrystEngComm (2014) 16, 22 4706
a=8.7032(2)Å b=14.5604(5)Å c=15.5676(5)Å
α=64.602(2)° β=77.240(2)° γ=83.635(2)°
C30H27ClLaN5O14
C30H27ClLaN5O14
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.55740(10)Å b=12.6056(2)Å c=18.9892(3)Å
α=106.1310(10)° β=98.9710(10)° γ=100.4790(10)°
C30H27CeClN5O14
C30H27CeClN5O14
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.5251(3)Å b=12.5605(4)Å c=18.9231(6)Å
α=106.077(3)° β=98.874(3)° γ=100.643(3)°
C30H27ClN5O14Pr
C30H27ClN5O14Pr
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.5300(3)Å b=12.5401(4)Å c=18.8719(6)Å
α=105.932(3)° β=98.860(2)° γ=100.482(2)°
C30H27ClN5NdO14
C30H27ClN5NdO14
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.52970(10)Å b=12.6996(3)Å c=18.8203(3)Å
α=106.347(2)° β=98.6300(10)° γ=100.059(2)°
C30H27ClEuN5O14
C30H27ClEuN5O14
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.4977(3)Å b=12.6270(4)Å c=18.7072(4)Å
α=106.096(2)° β=98.452(2)° γ=100.275(2)°
C30H27ClN5O14Tb
C30H27ClN5O14Tb
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.53070(10)Å b=12.7016(3)Å c=18.8199(3)Å
α=106.349(2)° β=98.6290(10)° γ=100.060(2)°
C30H27ClDyN5O14
C30H27ClDyN5O14
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.4727(2)Å b=12.6520(4)Å c=18.6017(6)Å
α=106.106(3)° β=98.088(2)° γ=100.255(2)°
C30H27ClHoN5O14
C30H27ClHoN5O14
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.4644(2)Å b=12.7206(3)Å c=18.5539(5)Å
α=106.206(2)° β=97.893(2)° γ=100.266(2)°
C30H27ClN5O14Yb
C30H27ClN5O14Yb
Dalton transactions (Cambridge, England : 2003) (2015) 44, 26 11954-11962
a=9.4951(3)Å b=12.5595(4)Å c=18.9191(6)Å
α=106.107(3)° β=98.869(2)° γ=100.650(3)°
C12H14N4O2S,C7H6O3
C12H14N4O2S,C7H6O3
Crystal Growth & Design (2011) 11, 8 3489
a=8.0060(5)Å b=9.3913(5)Å c=13.4786(8)Å
α=74.611(3)° β=75.053(3)° γ=86.102(3)°
C12H14N4O2S,C7H6O4
C12H14N4O2S,C7H6O4
Crystal Growth & Design (2011) 11, 8 3489
a=7.9671(3)Å b=9.4629(4)Å c=13.9432(6)Å
α=73.662(2)° β=74.468(2)° γ=87.240(2)°
C12H14N4O2S,C6H8O2
C12H14N4O2S,C6H8O2
Crystal Growth & Design (2011) 11, 8 3489
a=8.6932(4)Å b=17.0624(7)Å c=14.2695(6)Å
α=90.00° β=106.554(3)° γ=90.00°
C12H14N4O2S,C7H4Cl2O2
C12H14N4O2S,C7H4Cl2O2
Crystal Growth & Design (2011) 11, 8 3489
a=8.1070(4)Å b=17.5194(8)Å c=14.7732(7)Å
α=90.00° β=93.767(3)° γ=90.00°
C12H14N4O2S,C7H7NO
C12H14N4O2S,C7H7NO
Crystal Growth & Design (2011) 11, 8 3489
a=8.4321(7)Å b=12.9690(11)Å c=17.5247(16)Å
α=90.00° β=94.200(6)° γ=90.00°
C12H14N4O2S,C7H6NO2
C12H14N4O2S,C7H6NO2
Crystal Growth & Design (2011) 11, 8 3489
a=8.3238(6)Å b=9.5864(8)Å c=14.0808(11)Å
α=109.249(2)° β=95.432(2)° γ=106.165(2)°
C12H14N4O2S,C11H8O3
C12H14N4O2S,C11H8O3
Crystal Growth & Design (2011) 11, 8 3489
a=6.7701(4)Å b=16.6846(11)Å c=18.9656(12)Å
α=90.00° β=90.00° γ=90.00°
2(C12H14N4O2S),C4H4O4,C2H3N
2(C12H14N4O2S),C4H4O4,C2H3N
Crystal Growth & Design (2011) 11, 8 3489
a=11.4148(7)Å b=20.1672(12)Å c=14.8653(9)Å
α=90.00° β=90.00° γ=90.00°
C12H14N4O2S,C11H8O3
C12H14N4O2S,C11H8O3
Crystal Growth & Design (2011) 11, 8 3489
a=12.1076(8)Å b=13.5903(9)Å c=14.7508(10)Å
α=77.7560(10)° β=66.1980(10)° γ=85.2370(10)°
C12H14N4O2S,C7H7NO2
C12H14N4O2S,C7H7NO2
Crystal Growth & Design (2011) 11, 8 3489
a=8.5398(4)Å b=18.2753(7)Å c=13.3498(5)Å
α=90.00° β=105.792(2)° γ=90.00°
C12H14N4O2S,C6H6N2O
C12H14N4O2S,C6H6N2O
Crystal Growth & Design (2011) 11, 8 3489
a=9.684(4)Å b=15.716(6)Å c=25.310(9)Å
α=90.00° β=90.00° γ=90.00°
FJI-C2
C108H34Cd7N24O52
Inorganic chemistry (2016) 55, 5 2641-2649
a=32.9676(3)Å b=32.9676(3)Å c=26.6956(4)Å
α=90.00° β=90.00° γ=90.00°